NewEdge Advisors’s Recursion Pharmaceuticals RXRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $56K | Buy |
11,061
+2,428
| +28% | +$12.3K | ﹤0.01% | 2630 |
|
|
2025
Q1 | $45.7K | Buy |
8,633
+786
| +10% | +$4.16K | ﹤0.01% | 2579 |
|
|
2024
Q4 | $53K | Buy |
7,847
+2,387
| +44% | +$16.1K | ﹤0.01% | 2509 |
|
|
2024
Q3 | $36K | Buy |
5,460
+2,860
| +110% | +$18.8K | ﹤0.01% | 2535 |
|
|
2024
Q2 | $19.5K | Buy |
2,600
+500
| +24% | +$3.75K | ﹤0.01% | 2635 |
|
|
2024
Q1 | $20.9K | Hold |
2,100
| – | – | ﹤0.01% | 2614 |
|
|
2023
Q4 | $20.7K | Buy |
2,100
+464
| +28% | +$4.58K | ﹤0.01% | 2563 |
|
|
2023
Q3 | $12.5K | Buy |
+1,636
| New | +$12.5K | ﹤0.01% | 2502 |
|